Giovanni Perini

5PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer geneticsNeurology and neuromuscular diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 13, 2025
Systematic Targeting of GD2-Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector Platform.

Suleman Khan Zadran, Nicola Facchinello, Piergiuseppe De Rosa

|Jun 02, 2025
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.

Ruby Pandher, Chengyuan Xue, Laura D Gamble

|Jul 11, 2024
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

Jayne E Murray, Emanuele Valli, Giorgio Milazzo

|Mar 29, 2023
MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells.

Piergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran

|Feb 01, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Laura D Gamble, Stefania Purgato, Jayne Murray

Pageof 1